Phase 2 and 3 combination designs to accelerate drug development

Journal of the American Statistical Association

Volumn 100, Issue 470, 2005, Pages 493-502

  Liu, Qing ^a   Pledger, Gordon W ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adaptive design; Dose response study; Interim analysis; Step down test procedure; Trend test; Type I error rate

Indexed keywords

EID: 20444434001     PISSN: 01621459     EISSN: None     Source Type: Journal    
DOI: 10.1198/016214504000001790     Document Type: Article

References (14)

1. Abelson, R. P., and Tukey, J. W. (1963), "Efficient Utilization of Non-Numerical Information in Quantitative Analysis: General Theory and the Case of Simple Order," The Annals of Mathematical Statistics, 34, 1347-1369.
2. Bauer, P., and Kieser, M. (1999), "Combining Different Phases in the Development of Medical Treatments Within a Single Trial," Statistics in Medicine, 18, 1833-1848.
3. Bristol, D. R. (1989), "Designing Clinical Trials for Two-Sided Multiple Comparisons With a Control," Controlled Clinical Trials, 10, 142-152.
4. Canner, P. L. (1983), "Monitoring of the Data for Evidence of Adverse or Beneficial Treatment Effects," Controlled Clinical Trials, 4, 467-483.
5. Lalonde, R. L. (1992), "Pharmacodynamics," in Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring (3rd ed.), eds. W. E. Evans, J. J. Schentag, and W. J. Jusko, Vancouver, WA: Applied Therapeutics, Chap. 4.
6. Liu, Q., Andersoo, K. M., and Pledger, G. W. (2004), "Benefit-Risk Evaluation of Multi-Stage Adaptive Designs," Sequential Analysis, 23, 317-331.
7. Liu, Q., and Chi, G. Y. H. (2001), "On Sample Size and Inference for Two-Stage Adaptive Designs," Biometrics, 57, 172-177.
8. Liu, Q., Proschan, M. A., and Pledger, G. W. (2002), "A Unified Theory of Two-Stage Adaptive Designs," Journal of the American Statistical Association, 97, 1034-1041.
9. Sampson, A. R., and Sill, M. (2004), "Drop-the-Loser Design: Normal Case," unpublished manuscript
10. Schaid, D. J., Wieand, S., and Therneau, T. M. (1990), "Optimal Two-Stage Screening Designs for Survival Comparisons," Biomttrika, 77, 507-513.
11. Tamhane, A. C., Hochberg, Y., and Dunnett, C. W. (1996), "Multiple Test Procedures for Dose Finding," Biometrics, 52, 21-37.
12. Thall, P. F., Simon, R., and Ellenberg, S. S. (1988), "Two-Stage Selection and Testing Designs for Comparative Clinical Trials," Biometrika, 75, 303-310.
13. Wagner, J. G. (1968), "Kinetics of Pharmacologic Response," Journal of Theoretical Biology, 20, 173-201.
14. Whitehead, J. (1986), "Sample Sizes for Phase II and Phase III Clinical Trials: An Integrated Approach," Statistics in Medicine, 5, 459-464.